Evaluation of P53 Mutation in Uterine Serous Carcinoma

被引：0
|
作者：
Bandyopadhyay, Sudeshna [1 ]
Elshaikh, Mohamed [2 ]
Abada, Evi [1 ]
Fucinari, Juliana [3 ]
Fehmi, Omar [4 ]
Ruterbusch, Julie [5 ]
Dyson, Greg [6 ]
Schultz, Daniel [7 ]
Cote, Michele [1 ]
Ali-Fehmi, Rouba [1 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Karmanos Canc Inst, Detroit, MI USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Wayne State Univ, Sch Med, Detroit, MI USA
[6] Wayne State Univ, Detroit Med Ctr, Detroit, MI USA
[7] Henry Ford Hlth Syst, Detroit, MI USA
来源：
MODERN PATHOLOGY | 2021年 / 34卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
539
引用
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [31] Significant Overexpression of HMGAs in Serous Ovarian Carcinoma in Association with p53
    Mahajan, A.
    Gellert, L.
    Yang, X. J.
    Wei, J.
    LABORATORY INVESTIGATION, 2009, 89 : 226A - 226A
  • [32] Micropapillary serous carcinoma of the ovary: An immunohistochemical and mutational analysis of p53
    Katabuchi, H
    Tashiro, H
    Cho, KR
    Kurman, RJ
    Ellenson, LH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1998, 17 (01) : 54 - 60
  • [33] p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma
    Mineta, H
    Borg, Å
    Dictor, M
    Wahlberg, P
    Åkervall, J
    Wennerberg, J
    BRITISH JOURNAL OF CANCER, 1998, 78 (08) : 1084 - 1090
  • [34] p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma
    H Mineta
    Å Borg
    M Dictor
    P Wahlberg
    J Åkervall
    J Wennerberg
    British Journal of Cancer, 1998, 78 : 1084 - 1090
  • [35] P53 evaluation in urothelial bladder carcinoma
    Goupou, E.
    Moustakas, G.
    Nikolaidou, A.
    Manoloutsiou, I. Michalopoulou
    Klampatsas, A.
    Sarakapinas, G.
    Dimasis, N.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 345 - 345
  • [36] The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma
    Macwhinnie, N
    Monaghan, H
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (05) : 938 - 946
  • [37] Null Pattern Aberrant p53 Staining is more Frequent in Uterine High-Grade Endometrioid Carcinoma Compared to Serous Carcinoma
    Ladwig, Nicholas
    Garg, Karuna
    Joehlin-Price, Amy
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1092 - 1092
  • [38] Null Pattern Aberrant p53 Staining is more Frequent in Uterine High-Grade Endometrioid Carcinoma Compared to Serous Carcinoma
    Ladwig, Nicholas
    Garg, Karuna
    Joehlin-Price, Amy
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1092 - 1092
  • [39] P53 GENE MUTATION SPECTRUM IN HEPATOCELLULAR-CARCINOMA
    ODA, T
    TSUDA, H
    SCARPA, A
    SAKAMOTO, M
    HIROHASHI, S
    CANCER RESEARCH, 1992, 52 (22) : 6358 - 6364
  • [40] p53 mutation as a prognostic marker in advanced laryngeal carcinoma
    Bradford, CR
    Zhu, S
    Poore, J
    Fisher, SG
    Beals, TF
    Thoraval, D
    Hanash, SM
    Carey, TE
    Wolf, GT
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1997, 123 (06) : 605 - 609
12345